Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 57 (12) , 1594-1596
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- COX-2 inhibition as a treatment approach in schizophrenia: Immunological considerations and clinical effects of celecoxib add-on therapyEuropean Archives of Psychiatry and Clinical Neuroscience, 2004
- Cyclooxygenase inhibitor modulation of dopamine-related behavioursEuropean Journal of Pharmacology, 2002
- Beneficial Antipsychotic Effects of Celecoxib Add-On Therapy Compared to Risperidone Alone in SchizophreniaAmerican Journal of Psychiatry, 2002
- Role of Cyclooxygenase-2 in Neuronal Cell Cycle Activity and Glutamate-Mediated ExcitotoxicityThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Validation of the Scale of Functioning in Older Outpatients With SchizophreniaThe American Journal of Geriatric Psychiatry, 1996
- A depression rating scale for schizophrenicsSchizophrenia Research, 1990
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987
- Negative Symptoms in SchizophreniaArchives of General Psychiatry, 1982
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970